DNMT3A and cancer: -Specific interaction with cyclin-dependent kinase-1 (CDK1)-Five hydrogen bond interactions between DNMT1 and pelargonidin-Five hydrogen bond interactions between the ADD domain of DNMT3A and pelargonidin-Good interaction with DNMT1-Inhibited the recognition of an unmethylated site⇒ Pelargonidin can serve as a multitargetinhibitor for cancer treatment